Platelet-rich plasma use for shoulder epicondylitis treatment

A. A. Ochkurenko; Очкуренко А. А.; S. N. Savelyev; Савельев С. Н.; T. O. Baymatov; Байматов Т. О.

doi:10.17816/vto202027198-102

Platelet-rich plasma use for shoulder epicondylitis treatment

Authors: Ochkurenko A.A.¹, Savelyev S.N.², Baymatov T.O.¹
Affiliations:
1. National medical research center for traumatology and orthopedics named after N.N. Priorov
2. Clinical Hospital №6
Issue: Vol 27, No 1 (2020)
Pages: 98-102
Section: Articles
URL: https://journal-vniispk.ru/0869-8678/article/view/25891
DOI: https://doi.org/10.17816/vto202027198-102
ID: 25891

Cite item

Full Text

Abstract
Full Text
About the authors
References
Supplementary files
Statistics

Abstract

Epicondylitis is the most common cause of elbow pain, affecting up to 3,0% of the adult population. A comparative study of platelet-rich plasma (BTP) and betamethasone (diprospan) in the treatment of epicondylitis of the shoulder. 50 patients received injections of betamethasone 2-fold with an interval of 14 days. The main group-50 patients received 2 injections of BTP with an interval of 14 days. The results were evaluated using the psychometric scale Patient-Rated Tennis Elbow Evaluation (PRTEE) after 1, 6 and 12 months. Patients receiving Betamethasone showed the lowest level of pain after 1 month, with a gradual tendency to reduce the clinical effect after 6 months and the increase in clinical symptoms of the disease after 12 months. after treatment. The clinical effect after the use of BTP increases to 6 months with a slight tendency to reduce the effect to 12 months. Our studies have shown a high, up to 86,0% effectiveness of the applied methods of treatment of internal and external epicondylitis of the shoulder using PRP in comparison with glucorticosteroids.

Keywords

epicondylitis, glucocorticosteroids, betamethasone, platelet-rich plasma

Full Text

##article.viewOnOriginalSite##

References

Shiri R, Viikari-Juntura E, Varonen H, Heliövaara M. Preva- lence and determinants of lateral and medial epicondylitis: a population study. Am J Epidemiol. 2006;164(11):1065–1074. doi: 10.1093/aje/kwj325.
Беленький А.Г. Эпикондилит // РМЖ. — 2006. — Т.14. — №25. — C. 1786. [Belen’kii AG. Epikondilit. RMZh. 2006;14(25):1786. (In Russ).]
Varshney A, Maheshwari R, Juyal A, et al. Autologous platelet-rich plasma versus corticosteroid in the manage- ment of elbow epicondylitis: a randomized study. Int J Appl Basic Med Res. 2017;7(2):125–128. doi: 10.4103/2229- 516X.205808.
Наговицын Е.С. Осложнения после местного применения гидрокортизона // Клiнiчна хiрургiя. — 1977. — №3. — С. 51–53. [Nagovitsyn ES. Oslozhneniya posle mestnogo primeneniya gidrokortizona. Klin Khir. 1977;(3):51–53. (In Russ).]
Saccomanni B. Corticosteroid injection for tennis elbow or lateral epicondylitis: a review of the literature. Curr Rev Musculoskelet Med. 2010;3(1–4):38–40. doi: 10.1007/s12178- 010-9066-3. RETRACTION IN Erratum to: Corticosteroid injection for tennis elbow or lateral epicondylitis: a review of the literature. [Curr Rev Musculoskelet Med. 2012]
Edwards SG, Calandruccio JH. Autologous blood injec- tions for refractory lateral epicondylitis. J Hand Surg Am. 2003;28(2):272–278. doi: 10.1053/jhsu.2003.50041.
Мозолевский Ю.В. Ботокс возвращает на корт // Теннис и гольф. — 2000. — №3. — С. 5. [Mozolevskii YuV. Botoks vozvrashchaet na kort. Tennis i gol’f. 2000;(3):5. (In Russ).]
Galvin R, Callaghan C, Chan WS, et al. Injection of botu- linum toxin for treatment of chronic lateral epicondylitis: systematic review and meta-analysis. Semin Arthritis Rheum. 2011;40(6):585–587. doi: 10.1016/j.semarthrit.2011.01.003.
Wong SM, Hui AC, Tong PY, et al. Treatment of lateral epi- condylitis with botulinum toxin: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2005;143(11):793– 797. doi: 10.7326/0003-4819-143-11-200512060-00007.
Tosun HB, Gumustas S, Agir I, et al. Comparison of the effects of sodium hyaluronate-chondroitin sulphate and cor- ticosteroid in the treatment of lateral epicondylitis: a prospec- tive randomized trial. J Orthop Sci. 2015;20(5):837–843. doi: 10.1007/s00776-015-0747-z.
Chung B, Wiley JP. Effectiveness of extracorporeal shock wave therapy in the treatment of previously untreated lateral epicondylitis: a randomized controlled trial. Am J Sports Med. 2004;32(7):1660–1667. doi: 10.1177/0363546503262806.
Kazemi M, Azma K, Tavana B, et al. Autologous blood ver- sus corticosteroid local injection in the short-term treatment of lateral elbow tendinopathy: a randomized clinical trial of efficacy. Am J Phys Med Rehabil. 2010;89(8):660–667. doi: 10.1097/PHM.0b013e3181ddcb31.
Wolf JM, Ozer K, Scott F, et al. Comparison of autologous blood, corticosteroid, and saline injection in the treatment of lateral epicondylitis: a prospective, randomized, controlled multicenter study. J Hand Surg Am. 2011;36(8):1269–1272. doi: 10.1016/j.jhsa.2011.05.014.
Guler NS, Sargin S, Sahin N. Efficacy of extracorpore- al shockwave therapy in patients with lateral epicondylitis: a randomized, placebo-controlled, double-blind clinical trial. North Clin Istanb. 2018;5(4):314–318. doi: 10.14744/ nci.2017.82435.
Pietrzak WS, Eppley BL. Platelet rich plasma: biology and new technology. J Craniofac Surg. 2005;16(6):1043–1054. doi: 10.1097/01.scs.0000186454.07097.bf.
Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg. 2004;114(6):1502– 1508. doi: 10.1097/01.prs.0000138251.07040.51.
Rompe JD, Overend TJ, MacDermid JC. Validation of the patient-rated tennis elbow evaluation questionnaire. J Hand Ther. 2007;20(1):3–10. doi: 10.1197/j.jht.2006.10.003.
Pruce AM, Miller JA, Berger IR. Anatomic landmarks in joint paracentesis. Clin Symp. 1964;16:19–30.
Chen X, Jones IA, Park C, Vangsness CT Jr. The ef- ficacy of platelet-rich plasma on tendon and ligament healing: a systematic review and meta-analysis with bias assessment. Am J Sports Med. 2018;46(8):2020–2032. doi: 10.1177/0363546517743746.
Houck DA, Kraeutler MJ, Thornton LB, et al. Lateral epicon- dylitis with autologous blood, platelet-rich plasma, or corti- costeroid injections: a systematic review of overlapping meta- analyses. Orthop J Sports Med. 2019;7(3):2325967119831052. doi: 10.1177/2325967119831052.